Japanese Pharmaceutical Market

Pharmaceutical companies face many challenges in Japan in terms of its complex regulatory and pricing process. Regular price cuts also pose hurdles for the introduction of new innovative drugs. Despite these challenges, the world’s second largest pharmaceutical market presents a number of opportunities.

Highlights in this white paper include:

The result of the measures taken by Japan to reduce the drug lag period
A discussion into the difficulties in obtaining price premiums at launch
The effect of market expansion re-pricing rules
Exploration into the efforts to increase the uptake of generics and the impact of this on branded manufacturers
Advantages in the Japanese pharmaceutical market